Free potassium ion (K⁺)

Free potassium ion (K⁺) is one of the primary physiological cations, found at high concentration inside cells and much lower concentration in extracellular fluids. It is not a protein, receptor, enzyme, or classical drug target, but rather an inorganic ion that plays an essential role in generating and maintaining the resting membrane potential in all excitable cells, such as neurons and muscle fibers. Transmembrane gradients of potassium (and sodium) drive the electrical signaling fundamental to nervous system and cardiac function; small changes in extracellular K⁺ can have major physiological or pathological consequences, such as arrhythmias or neuromuscular paralysis. Drugs do not bind to free K⁺ as a molecular target, but therapies may alter potassium balance (such as diuretics, potassium binders, or supplementation) or modulate potassium channel activity, which in turn changes K⁺ flux across membranes[1][4][5]. Free potassium is monitored as a biomarker for various diseases, but the ion itself is not a direct therapeutic target. - “Free potassium ions” is not a correct molecular target: it refers to an elemental ion, not a discrete gene, protein, or targetable macromolecule[1][5][6]. The direct molecular targets in potassium-related therapeutics are generally *potassium channels* rather than potassium ions themselves. - Typical structured drug target databases (e.g., UniProt, ChEMBL) do not include “free potassium ions” as druggable targets; instead, “potassium channel” proteins are the relevant entries[3][4][6].

Other names

Potassium ionK+Potassium cationExtracellular potassium